Proclara Biosciences' Series D Round

Proclara Biosciences raised a round of funding on March 25, 2014.

Proclara Biosciences, formerly NeuroPhage Pharmaceuticals, is a biotechnology company advancing product candidates developed based on proprietary GAIM technology, which is capable of simultaneously ta…

Articles about Proclara Biosciences' Series D Round: